CVS Health Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#2A0CD0;color: white;font-size:3em;padding-top: 30px;;'>CVS</div>
CVS -- USA Stock  

Earning Report: February 12, 2020  

Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding CVS Health Corporation is 'Buy'. Macroaxis provides CVS Health buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CVS positions. The advice algorithm takes into account all of CVS Health available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CVS buy-and-hold prospective. Continue to CVS Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Execute Advice
Sell CVS HealthBuy CVS Health


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon CVS Health Corporation has a risk adjusted performance of 0.0938, jensen alpha of 0.0816, total risk alpha of (0.023985), sortino ratio of 0.048 and treynor ratio of 0.2086
Macroaxis provides unbiased buy, hold, or sell recommendation on CVS Health that should be used to complement current analysts and expert consensus on CVS Health Corporation. Our buy or sell advice engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure CVS Health is not overpriced, please confirm all CVS Health fundamentals including its Revenue, Cash Flow from Operations, Current Asset, as well as the relationship between Cash per Share and Beta . Given that CVS Health has Price to Earning of 19.43 , we suggest you validate CVS Health Corporation market performance and probability of bankruptcy to make sure the company can sustain itself next year given your prevailing risk tolerance and investing horizon.

CVS Health Trading Alerts and Improvement Suggestions

CVS Health has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial commitments
The company has 91.92 B in debt with debt to equity (D/E) ratio of 149.2 . This implies that the company may be unable to create cash to meet all of its financial commitments. CVS Health has Current Ratio of 0.93 suggesting that it has not enough short term capital to pay financial commitments when the payables are due.
Over 80.0% of CVS Health shares are held by institutions such as insurance companies
Latest headline from MacroaxisInsider: CVS Health exotic insider transaction detected

CVS Health current analysts recommendations

Target Median Price83.00
Target Mean Price81.71
Recommendation Mean2.10
Target High Price97.00
Number Of Analyst Opinions24
Target Low Price69.00

CVS Health Returns Distribution Density

Mean Return0.16Value At Risk1.84
Potential Upside1.76Standard Deviation1.23
 Return Density 

CVS Health Greeks

Alpha over DOW
Beta against DOW=0.73
Overall volatility
Information ratio =0.045

CVS Health Volatility Alert

CVS Health Corporation has relatively low volatility with skewness of 0.74 and kurtosis of 4.0. However, we advise all investors to independently investigate CVS Health Corporation to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.
 Better Than Average     
 Worse Than Average Compare CVS Health to competition

CVS Health Fundamental Vs Peers

FundamentalsCVS HealthPeer Average
Return On Equity(0.0002) (0.31) 
Return On Asset(0.0037) (0.14) 
Profit Margin(0.002771) (1.27) 
Operating Margin6.56 (5.51) 
Current Valuation171.47 B16.62 B
Shares Outstanding1.3 B571.82 M
Shares Owned by Insiders0.18 10.09 
Shares Owned by Institutions79.65 39.21 
Number of Shares Shorted20.25 M4.71 M
Price to Earning19.43 28.72 
Price to Book1.50 9.51 
Price to Sales0.40 11.42 
Revenue226.05 B9.43 B
Gross Profit30.88 B27.38 B
EBITDA14.83 B3.9 B
Net Income4.32 B570.98 M
Cash and Equivalents8.53 B2.7 B
Cash per Share6.55 5.01 
Total Debt91.92 B5.32 B
Debt to Equity149.20 48.70 
Current Ratio0.95 2.16 
Book Value Per Share53.14 1.93 K
Cash Flow from Operations13.55 B971.22 M
Short Ratio3.74 4.00 
Earnings Per Share3.65 3.12 
Price to Earnings To Growth3.63 4.89 
Number of Employees295 K18.84 K
Market Capitalization90.01 B19.03 B
Total Asset93.66 B29.47 B
Retained Earnings42.25 B9.33 B
Working Capital7.21 B1.48 B
Current Asset30.38 B9.34 B
   CVS Health exotic insider transaction detected [view details]